Forbes @Forbes
Pfizer said it will make its entire portfolio of patented medicines and vaccines available to low-income countries on a not-for-profit basis in a bid to narrow the global healthcare gap that came under renewed scrutiny during the Covid-19 pandemic. https://t.co/IC8Dji97f2 https://t.co/Qvd6SLSJUh — PolitiTweet.org
